期刊文献+

修剪神经纤维缠结

TRIMming the tangles
原文传递
导出
摘要 Tau protein (encoded by the MAPT gene) is an attractive therapeutic target for the treatment of Alzheimer’s disease (AD) and other “tauopathies”, where aggregated tau pathology accumulates in neurons. Since tau deposition is strongly associated with cognitive dysfunction in AD, and tau purportedly mediates the toxicity of β-amyloid, therapies developed to reduce tau or its phosphorylation have been tested preclinically and in several small-scale clinical trials[1]. However, caveats for tau-targeting therapy include the limited understanding of its physiological functions and the complicated interactions between its post-translational modifications, aggregation, and cellular toxicity.
作者 雷鹏 Scott Ayton Peng Lei;Scott Ayton(Department of Neurology and State Key Laboratory of Biotherapy,National Clinical Research Center for Geriatrics,West China Hospital,Sichuan University,Chengdu 610041,China;The Florey Neuroscience Institute,The University of Melbourne,Melbourne VIC 3052,Australia)
出处 《Science Bulletin》 SCIE EI CAS CSCD 2023年第21期2507-2509,共3页 科学通报(英文版)
基金 supported by the National Clinical Research Center for Geriatrics of West China Hospital (Z2021LC001) the West China Hospital 1.3.5 Project for Disciplines of Excellence(ZYYC20009)。
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部